A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes

Joseph S. Koopmeiners, Jaime Modiano

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences